Table 3.
Baseline predictors of incident diabetes including either one of or both markers of preclinical CV disease
| HR | CI 95.0% HR |
P≤ | ||
|---|---|---|---|---|
| Lower | Upper | |||
| Age (years) | 1.02 | 1.00 | 1.03 | 0.028 |
| MetS (n/y) | 2.73 | 2.21 | 3.37 | 0.0001 |
| Family history of diabetes (n/y) | 1.85 | 1.51 | 2.27 | 0.0001 |
| LVH or CA (n/y) | 1.70 | 1.33 | 2.17 | 0.0001 |
| LVH and CA (n/y) | 1.93 | 1.42 | 2.63 | 0.0001 |
| Heart rate (b.p.m.) | 0.99 | 0.99 | 1.01 | 0.762 |
| Duration of hypertension (years) | 1.01 | 0.99 | 1.02 | 0.270 |
| Number of antihypertensive drugs | 1.09 | 0.95 | 1.24 | 0.213 |
| CCB (n/y) | 0.99 | 0.78 | 1.27 | 0.920 |
| β-Blockers (n/y) | 1.04 | 0.82 | 1.32 | 0.749 |
MetS, metabolic syndrome; LVH, left ventricular hypertrophy; CA, carotid atherosclerosis; CCB, calcium channel blockers; β-blockers, beta-blockers.